Dementia in Parkinson disease - Functional imaging of cholinergic and dopaminergic pathways
Dementia in Parkinson disease - Functional imaging of cholinergic and dopaminergic pathways
复制标题
DOI:
10.1212/01.wnl.0000191154.78131.f6
复制
发表时间:
2005-12-13
期刊:
影响因子:
9.9
通讯作者:
Heiss, WD
中科院分区:
文献类型:
--
作者:
Hilker, R;Thomas, AV;Heiss, WD
Objective: To assess neurochemical deficits in patients with Parkinson disease (PD) associated dementia (PDD) in vivo. Methods: The authors performed combined PET with N-[C-11]-methyl-4-piperidyl acetate (MP4A) and F-18-fluorodopa (FDOPA) for evaluation of cholinergic and dopaminergic transmitter changes in 17 non-demented patients with PD and 10 patients with PDD. Data were compared to 31 age-matched controls by a combined region-of-interest and voxel-based Statistical Parametric Mapping analysis. Results: The striatal FDOPA uptake was significantly decreased in PD and PDD without differences between the groups. The global cortical MP4A binding was severely reduced in PDD ( 29.7%, p < 0.001 vs controls) and moderately decreased in PD (10.7%, p < 0.01 vs controls). The PDD group had lower parietal MP4A uptake rates than did patients with PD. Frontal and temporo-parietal cortices showed a significant covariance of striatal FDOPA reduction and decreased MP4A binding in patients with PDD. Conclusions: While non-demented patients with Parkinson disease had a moderate cholinergic dysfunction, subjects with Parkinson disease associated dementia (PDD) presented with a severe cholinergic deficit in various cortical regions. The finding of a closely associated striatal FDOPA and cortical MP4A binding reduction suggests a common disease process leading to a complex transmitter deficiency syndrome in PDD.